Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: A meta-regression analysis of randomized trials.

Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: A meta-regression analysis of randomized trials / Tarantini, G; Brener, Sj; Barioli, A; Gratta, A; Parodi, Guido; Rossini, R; Navarese, Ep; Niccoli, G; Frigo, Ac; Musumeci, G; Iliceto, S; Stone, G. W.. - In: AMERICAN HEART JOURNAL. - ISSN 0002-8703. - 167(3):3(2014), pp. 401-412. [10.1016/j.ahj.2013.11.013.]